ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Anti-LG3 Antibodies Enhance Renal Microvascular Rarefaction, Fibrosis and Dysfunction Associated with Ischemia-Reperfusion Injury.

    B. Yang,1,3 K. Hamelin,1,3 M. HÉnault-Rondeau,1,3 N. Patey,1,2,3 J. Turgeon,1,3 S. Lan,1,3 L. Pomerleau,1 J. Peng,1 J. Tremblay,1 M. DieudÉ,1,3 M.-J. HÉbert,1,3 H. Cardinal.1,3

    1Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada; 2Department of Pathology, CHU Ste-Justine, Montreal, QC, Canada; 3Canadian National Transplant Research Program, CNTRP, Canada.

    Delayed graft function (DGF) is associated with decreased kidney graft survival. We have shown that pre-transplant anti-LG3 autoantibodies were associated with increased risk of DGF…
  • 2016 American Transplant Congress

    Ineligible: Attitudes and Follow-Up of Individuals Ruled Out of Living Kidney Donation.

    D. Dobosz,1 C. Thiessen,1 J. Gannon,1 S. Li,1 K. Kennedy,2 D. Gray,3 A. Mussell,3 E. Gordon,2 S. Kulkarni,1 P. Reese.3

    1Yale U, New Haven; 2Northwestern U, Chicago; 3U Pennsylvania, Philadelphia.

    Background: Little is known about the experiences of individuals who begin living kidney donor (LKD) evaluation but are turned down due to ineligibility. We assessed…
  • 2016 American Transplant Congress

    Effect of Baseline Proteinuria on Long- and Short-Term Outcomes in Live Kidney Donors – 10 Year U.K Cohort Study.

    N. Krishnan,1 L. Bradbury,2 N. Raymond.1

    1Renal & Transplantation, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, United Kingdom; 2Statistics, National Health Service, Organ Donation & Transplant, Bristol, United Kingdom.

    Living kidney donation has significantly improved recipient and graft survival world wide. It is importanat to have a better understanding of the outcomes and risks…
  • 2016 American Transplant Congress

    Risk Stratification for Optimized Utilization of Deceased Donor Kidneys with Acute Kidney Injury by KDIGO Criteria.

    B. Yu,1 T. Koo,2 J. Lee,3 J. Yang,2 J. Ha,4 C. Ahn,1 Y. Kim,1 H. Lee.1

    1Internal Medicine, Seoul National University Hospital, Seoul, Korea; 2Transplantation Center, Seoul National University Hospital, Seoul, Korea; 3Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; 4General Surgery, Seoul National University Hospital, Seoul, Korea.

    BackgroundDeceased donor kidneys with acute kidney injury (AKI) raise fear of poor graft outcomes to the transplant clinicians and consequently are often discarded. However, the…
  • 2016 American Transplant Congress

    Kidney Transplant Outcomes in Patients with CPRA Values >98% After Implementation of the New OPTN/UNOS Kidney Allocation System (KAS): A Single Center Study Update.

    N. Kaur,1 S. Goral,1 J. Kearns,2 P. Abt,3 A. Naji,3 P. Porrett,3 M. Levine,3 M. Kamoun.2

    1Renal, Electrolyte and Hypertension Division, University of Pennsylvania Medical Center, Philadelphia; 2Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia; 3Surgery, University of Pennsylvania Medical Center, Philadelphia.

    Background: Sensitized patients have had prolonged waiting times and greater incidence of death while on the waiting list. On December 4, 2014, UNOS/OPTN activated a…
  • 2016 American Transplant Congress

    Tipping the Scales: Liver Transplant Outcomes of the Super Obese.

    R. Gedaly, J. Berger, X. Mei, F. Marti, L. Turcios, M. Shah.

    Surgery, University of Kentucky, Lexington.

    Objective: We aim to study outcomes in liver transplant recipients with BMI >50 using the UNOS database.Methods: We reviewed patients undergoing liver transplantation recorded in…
  • 2016 American Transplant Congress

    Intra-Operative Hepatic Arterial Flow Predicts Hepatic Artery Complications After Deceased Donor Liver Transplantation.

    H. Fernandez, G. Testa, G. Klintmalm, P. Kim.

    Baylor University, Dallas, TX.

    IntroductionHepatic arterial flow (HAF) is important for post liver transplant outcomes. This study was conducted to determine the predictive value of measured intraoperative HAF on…
  • 2016 American Transplant Congress

    Renal Vein Thrombosis Incidence in 3976 Consecutive Kidney Transplants: Retrospective Analyses Focusing on Intraoperative Risk Factors.

    H. Marinho Neto, B. Leslie, J. Neves Neto, J. Offerni, A. Pessoa, M. Almeida, M. Nogueira, S. Ximenes, W. Aguiar, H. Tedesco, J. Medina Pestana.

    Kidney Hospital, São Paulo, Brazil.

    INTRODUCTION: Although rare (incidence of 0,1 to 8.2%), renal vein thrombosis is a major cause o early graft loss. Here we try to identify perioperative…
  • 2016 American Transplant Congress

    Impact of Early Hospital Readmissions After Kidney Transplantation on Graft Function.

    I.-K. Kim, M. Ju, S. Son.

    Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

    Early hospital readmissions are common after kidney transplantation. We investigated the relationship between early hospital readmissions and clinical outcomes in a single-center retrospective study that…
  • 2016 American Transplant Congress

    Polyfunctionality of CD8 T Cell Responses to Cytomegalovirus in Transplant Patients.

    L. Higdon,1 K. Margulies,2 J. Maltzman.1,3

    1Stanford University, Palo Alto; 2University of Pennsylvania, Philadelphia; 3Veterans Administration Medical Center, Palo Alto.

    Background: Cytomegalovirus (CMV) infection causes significant morbidity including allograft damage in transplant patients. Primary infection with CMV is rapidly resolved in healthy individuals; memory T…
  • « Previous Page
  • 1
  • …
  • 173
  • 174
  • 175
  • 176
  • 177
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences